Columbia Large Cap Value Inst3 (CDEYX)
16.45
+0.15 (+0.92%)
USD |
May 25 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.67% | 2.570B | 1.50% | 27.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -189.89M | -0.67% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks a high level of current income and, as a secondary objective, steady growth of capital. The fund's assets primarily are invested in equity securities. Under normal market conditions, it will invest at least 80% of its net assets (including the amount of any borrowings for investment purposes) in common and preferred stocks of large capitalization companies. The fund may invest up to 25% of its net assets in foreign investments. It may from time to time emphasize one or more sectors in selecting its investments, including the financial services sector. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | INDZX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Equity-Income |
| Fund Owner Firm Name | Columbia Threadneedle |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Hugh Mullin | 8.82 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
81
-189.89M
-4.342B
Category Low
19.90B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 24, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 24, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Johnson & Johnson | 3.56% | 179.25 | -1.19% |
| Bank of America Corp | 2.82% | 35.91 | 0.73% |
| JPMorgan Chase & Co | 2.72% | 127.09 | 0.58% |
| Berkshire Hathaway Inc Class B | 2.44% | 308.68 | -0.16% |
| Procter & Gamble Co | 2.40% | 145.14 | -1.69% |
| Vertex Pharmaceuticals Inc | 2.33% | 270.73 | 0.84% |
| Merck & Co Inc | 2.25% | 93.78 | -0.90% |
| ConocoPhillips | 2.24% | 111.17 | 1.54% |
| Cigna Corp | 2.22% | 265.84 | 0.33% |
| EOG Resources Inc | 2.19% | 133.40 | 3.21% |
Basic Info
| Investment Strategy | |
| The investment seeks a high level of current income and, as a secondary objective, steady growth of capital. The fund's assets primarily are invested in equity securities. Under normal market conditions, it will invest at least 80% of its net assets (including the amount of any borrowings for investment purposes) in common and preferred stocks of large capitalization companies. The fund may invest up to 25% of its net assets in foreign investments. It may from time to time emphasize one or more sectors in selecting its investments, including the financial services sector. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | INDZX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Equity-Income |
| Fund Owner Firm Name | Columbia Threadneedle |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Hugh Mullin | 8.82 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-24-22) | 1.50% |
| 30-Day SEC Yield (4-30-22) | Upgrade |
| 7-Day SEC Yield (5-23-22) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 16.45 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of April 30, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 11/8/2012 |
| Last Annual Report Date | 5/31/2021 |
| Last Prospectus Date | 10/1/2021 |
| Share Classes | |
| ADECX | C |
| CDVZX | Inst |
| INDZX | A |
| RDEIX | Retirement |
| RDERX | Adv |
| RSEDX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |